iBio (IBIO) Interest Expenses (2010 - 2026)
iBio's (IBIO) quarterly Interest Expenses came in at $141000.0 in Q1 2026, little changed year-on-year from $141000.0 in Q1 2025, and little changed on a QoQ basis from $141000.0 in Q4 2025.
iBio (IBIO) Interest Expenses (2010 - 2026) Analysis & Trends
iBio (IBIO) has 17 years of Interest Expenses data on file, last reported at $141000.0 in Q1 2026.
- On a quarterly basis, Interest Expenses changed 0.0% year-over-year to $141000.0 in Q1 2026; TTM through Mar 2026 was $291000.0, a 401.72% increase from a year earlier, with the FY2025 full-year figure at $63.4 million, up 15.57% from the prior year.
- Interest Expenses for Q1 2026 stood at $141000.0, roughly flat from $141000.0 in the prior quarter.
- Over the last five years, Interest Expenses for IBIO reached as high as $3.6 million in Q4 2022 and fell as low as -$281000.0 in Q2 2024.
- Historically, Interest Expenses has averaged $623058.8 across 5 years, with a median of $141000.0 in 2024.
- Across the five-year window, Interest Expenses soared 1701.49% in 2022 and tumbled 145.25% in 2024, its largest moves.
- Year by year, Interest Expenses stood at $3.6 million in 2022, then plunged by 91.32% to $316000.0 in 2023, then plunged by 55.38% to $141000.0 in 2024, then changed by 0.0% to $141000.0 in 2025, then changed by 0.0% to $141000.0 in 2026.
- Per Business Quant data, the three most recent Interest Expenses figures were $141000.0 in Q1 2026, $141000.0 in Q4 2025, and $36000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | -42,141.15 |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 100,000.00 |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 32.89 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 420.30 Mn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 28.30 Mn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 1.17 Bn |
| 10 | iBio | 172.22 Mn | 172.22 Mn | - | 141,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 141,000.00 |
| Mar 31, 2026 | 141,000.00 |
| Dec 31, 2025 | 141,000.00 |
| Dec 31, 2025 | 141,000.00 |
| Sep 30, 2025 | 36,000.00 |
| Sep 30, 2025 | 36,000.00 |
| Jun 30, 2025 | -27,000.00 |
| Jun 30, 2025 | -27,000.00 |
| Mar 31, 2025 | 141,000.00 |
| Mar 31, 2025 | 141,000.00 |
| Dec 31, 2024 | 141,000.00 |
| Dec 31, 2024 | 141,000.00 |
| Sep 30, 2024 | 57,000.00 |
| Sep 30, 2024 | 57,000.00 |
| Jun 30, 2024 | -281,000.00 |
| Jun 30, 2024 | -281,000.00 |
| Mar 31, 2024 | 141,000.00 |
| Mar 31, 2024 | 141,000.00 |
| Dec 31, 2023 | 316,000.00 |
| Dec 31, 2023 | 316,000.00 |